Open AccessMRPL13 Act as a Novel Therapeutic Target and Could Promote Cell Proliferation in Non-Small Cell Lung Cancer
Author(s) -
Chuanqing Jing,
Rong Fu,
Can Wang,
Xiurong Li,
Wei Zhang
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s316428
Subject(s) - lung cancer , cancer research , gene knockdown , pi3k/akt/mtor pathway , biology , a549 cell , cell growth , protein kinase b , cd8 , immunotherapy , cancer , cell culture , immunology , medicine , oncology , signal transduction , immune system , microbiology and biotechnology , genetics
The latent involvement of MRPL13 in non-small cell lung cancer (NSCLC) remains unclear. This study aimed to explore the role of MRPL13 in NSCLC.